Enhanced generation of reactive species by cold plasma in gelatin solutions for selective cancer cell death by Labay, Cédric Pierre et al.
This document is confidential and is proprietary to the American Chemical Society and its authors. Do not 
copy or disclose without written permission. If you have received this item in error, notify the sender and 
delete all copies.
Enhanced Generation of Reactive Species by Cold Plasma in 
Gelatin Solutions for Selective Cancer Therapy
Journal: ACS Applied Materials & Interfaces
Manuscript ID Draft
Manuscript Type: Article
Date Submitted by the 
Author: n/a
Complete List of Authors: Labay, Cedric; Universitat Politecnica de Catalunya
Roldan, Marcel; Universitat Politecnica de Catalunya
Tampieri, Francesco; Universitat Politecnica de Catalunya, Department of 
Materials Science and Metallurgy
Stacampiano, Augusto; GREMI
Escot Bocanegra, Pablo; GREMI
Ginebra, Maria-Pau; Universitat Politecnica de Catalunya, Department of 
Materials Science and Metallurgical Engineering
Canal, Cristina; Universitat Politecnica de Catalunya, Materials Science 
and Engineering Department
 
ACS Paragon Plus Environment
ACS Applied Materials & Interfaces
1
Enhanced Generation of Reactive Species by Cold Plasma in 
Gelatin Solutions for Selective Cancer Therapy
Cédric Labay1,2,3, Marcel Roldán1,2, Francesco Tampieri1,2,3, Augusto Stancampiano4, 
Pablo Escot Bocanegra4, Maria-Pau Ginebra1,2,3,5, Cristina Canal1,2,3 
1 Biomaterials, Biomechanics and Tissue Engineering Group, Universitat Politècnica de 
Catalunya (UPC), Av. Eduard Maristany 10-14, 08019 Barcelona, Spain
2 Barcelona Research Center in Multiscale Science and Engineering, UPC, Barcelona, Spain
3 Research Centre for Biomedical Engineering (CREB), UPC, 08019 Barcelona, Spain
4 GREMI, UMR 7344, CNRS/Université d’Orléans, BP 6744, CEDEX 2, 45067 Orléans, France




Atmospheric pressure plasma jets generate reactive oxygen and nitrogen species (RONS) in 
liquids and biological media, which find application in the new area of plasma medicine. These 
plasma-treated liquids demonstrated recently to possess selective properties on killing cancer 
cells and attract attention towards new plasma-based cancer therapies. These allow for local 
delivery by injection in the tumor but can be quickly washed away by body fluids. By confining 
these RONS in a suitable biocompatible delivery system, great perspectives can be opened in 
the design of novel biomaterials aimed for cancer therapies. Gelatin solutions are evaluated here 
to store RONS generated by atmospheric pressure plasma jets, and their release properties are 
evaluated. The concentration of RONS was studied in 2% gelatin as a function of different plasma 
parameters (treatment time, nozzle distance and gas flow) with two different plasma jets. Much 
higher production of reactive species (H2O2 and NO2-) was revealed in the polymer solution than 
in water after plasma treatment. The amount of RONS generated in gelatin is greatly improved 
with respect to water, with concentrations of H2O2 and NO2- between 2 and 12 times higher for 
the longest plasma treatments. Plasma-treated gelatin exhibited the release of these RONS to a 
liquid media, which induced an effective killing of bone cancer cells. Indeed, in vitro studies on 
Sarcoma Osteogenic (SaOS-2) cell line exposed to plasma-treated gelatin lead to time-
dependent increasing cytotoxicity with the longer plasma treatment time of gelatin. While SaOS-
2 cell viability decreased down to 12%-23% after 72 hours for cells exposed to 3-min treated 
gelatin, viability of healthy cells (hMSC) was preserved (around 90%), establishing the selectivity 
of the plasma-treated gelatin on cancer cells. This sets the basis for designing improved 
hydrogels with high capacity to deliver RONS locally to tumors. 
Keywords: Cold atmospheric plasma; hydrogel; osteosarcoma; reactive oxygen and nitrogen 
species.
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The potential of targeting the oxidative stress response in cancer cells that could overcome drug 
resistance and spare normal tissue is being investigated as novel treatment by different 
techniques. Production of reactive oxygen and nitrogen species (RONS) in liquids (water, saline 
solutions, cell culture media) by treatment with cold atmospheric plasmas has been focus of 
interest in the last years due to its implications in biology and medicine (i.e. from wound healing 
to cancer treatment). Thus, the generation of species such as H2O2, NO2-, O3- or short-lived 
species has been extensively described 1–4. The plasma-treated or plasma-conditioned liquids 
(PCL) with biological effects provide a new window of opportunities for local treatment by 
injecting in the disease site. Taking advantage of the different basal levels of oxidative stress 
between healthy and cancer cell lines5–8, and the different sensitivity to reactive oxygen species 
(ROS), previous works demonstrated the selective effects of PCL on killing cancer cells9–15. 
However, injection of PCL to the tumor may quickly be washed away by body fluids, so design 
of suitable biomaterials for delivery of these oxidative stress is of paramount importance. In this 
sense, and to also foster higher concentrations of RONS in suitable biocompatible vehicles 
studies on PCL were broadened to alginate solutions, that proved to be good candidates to 
enhance generation of RONS 16. Therefore, developing vehicles of these RONS for enhanced local 
delivery to the diseased site would be a very interesting asset.
Gelatin is a translucid and thermosensitive hydrogel derived from collagen. Since collagen is the 
most abundant extracellular matrix protein in humans and animals, and the main component of 
connective tissues (such as skin, ligament, tendons, etc.), gelatin presents a high 
biocompatibility, making it a great candidate to be used in the design of hydrogel-based 
implantable biomaterials. Indeed, as biomaterials for tissue engineering, a wide diversity of 
gelatin-based structures have been described in literature17 including nano- and micro-
spheres18,19 or particles, 3D scaffolds20–24, electrospun nanofibers25–27, cryogel scaffolds28, 
composite materials29–31 and in situ gelling formulations. This reverts in a broad range of 
applications going from drug and growth factors delivery18,19,30 to tissue repair and regeneration 
for ocular23, bone30, skeletal muscle32 or soft tissue24,31 engineering.
The first studies involving cold atmospheric plasma treatment of gelled gelatin used it as a 
surrogate of human tissues – i.e. skin - to study its barrier effects on incoming RONS generated 
by different kinds of plasma treatment (plasma jet, barrier discharge). The penetration of RONS 
through gelatin gel films was quantified measuring the concentrations in the water underneath 
such films33–35. Other materials such as agarose36 and phospholipid membranes37 were 
employed to model living tissues, where the authors also focused on the transport and diffusion 
of the RONS through these layers. 
Here, we intend to describe for the first time the ability of gelatin solutions to successfully 
increase, store and deliver reactive species generated by cold atmospheric plasmas with the 
purpose to further include the plasma-treated biopolymer in the design of hydrogel-based 
biomaterial acting as vehicles of RONS for cancer therapy. A wide variety of plasma jets have 
been described, producing different biological effects, so here focus will be put on comparing a 
helium atmospheric pressure plasma jet (APPJ) to a standard commercial source argon jet 
(known as kINPen) on the production of RONS in gelatin and investigating its potential biological 
effects.
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Gelatin type B (Rousselot 250 LB8, Rousselot, France), in powder form and MilliQ water 
(MilliPore, Merck) (designated here as DI water) were used for preparation of biopolymer 
solution. Argon (Ar 5.0) and Helium (He 5.0) employed as precursor gas to generate plasma 
(PRAXAIR, Spain).
Sulfanilamide (Sigma-Aldrich, USA), N-(1-naphthyl)ethylenediamine dihydrochloride (Sigma-
Aldrich, USA) and ortho-phosphoric acid 85%, pure, pharma grade (H3PO4) (85%) (Panreac, USA) 
have been used for the preparation of Griess reagent, used for NO2- detection. Sodium nitrite 
(NaNO2, Sigma-Aldrich, USA) used for calibration curves of nitrites. Sodium azide (NaN3), 
Titanium(IV) oxysulfate-sulfuric acid solution (TiOSO4) and 30% (w/w) hydrogen peroxide (H2O2) 
solution used for detection of hydrogen peroxides in  water were purchased from Sigma Aldrich. 
AmplexTMRed reagent (InvitrogenTM, Thermo Fisher Scientific) and peroxidase from horseradish 
(Type VI) (HRP) (Sigma-Aldrich, USA) were used for determination of H2O2 in gelatin. 
NunclonTM Delta Surface 24-well and 96-well plates (ThermoFisher Scientific) and Corning® 
Transwell® polyester membrane cell culture inserts 6.5 mm Transwell® with 0.4 μm pore 
polyester membrane insert, TC-treated, sterile (Corning, Inc., USA) were used for in vitro cell 
experiments. Sarcoma osteogenic SaOS-2 (HTB-85, #70014245, ATCC, USA) were cultured in Mc 
Coy´s 5A medium (modified, with sodium bicarbonate, without L-glutamine, liquid, sterile-
filtered, suitable for cell culture), purchased from Sigma Aldrich. Bone marrow-derived 
Mesenchymal Stem Cells hMSC (PCS-500-012, #70014245, ATCC, USA) were cultured in 
Advanced Dulbecco’s Eagle Medium (1X) (AdvDMEM) (Gibco, ThermoFisher Scientific). To 
supplement cell culture media, Foetal Bovine Serum (FBS), Penicillin/Streptomycin (P/S) and 
Trypsin were purchased from ThermoFisher Scientific. Dulbecco’s Phosphate Buffered Saline 
(PBS) used for in vitro cell assay and release experiments were obtained from Biowest (Biowest 
SAS, France). For sample preparation for confocal microscopy, Tween 20 (Sigma-Aldrich), 
SuperBlock™ (TBS) (ThermoScientific, Ref. 37535, USA) Alexa Fluor® 546 Phalloidin 
(Invitrogen™), ProLong® Gold antifade with DAPI (InvitrogenTM, P36931, USA) were used.
2.2. Preparation of gelatin solution
Gelatin in powder form was mixed with MilliQ water at 37 ⁰C using magnetic stirring for 2 hours 
to obtain a 2% wt/wt gelatin solution. 2% gelatin solution was stored at 4 ⁰C and brought to 37 ⁰C 
before plasma treatment.
2.3. Plasma treatment
In his work, two plasma sources were employed: an APPJ, using helium as plasma gas and whose 
design is based on a single electrode as described in literature38 and a commercial kINPen® IND 
(NEOPLAS Tools, Germany)39 operating with argon. Plasma treatment times up to 5 minutes 
were performed to either water or gelatin solutions. Nozzle distance to the solution surface was 
tested from 10 mm to 20 mm. Gas flow, controlled by Ar and He Bronkhorst Mass View flow 
controllers (Bronkhorst®, Netherlands), was employed between 1 and 5 L/min for APPJ and 1 
and 2.5 L/min for kINPen due to the different configurations of the two plasma jets. To evaluate 
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the effects of APPJ and kINPen plasma treatment conditions on the amount of RONS generated 
in gelatin solution and the ageing of RONS, 200 µL of 2% gelatin solution previously warmed at 
37 ⁰C were put for treatment in a 96-well plate on a dielectric plate at floating potential Error! 
Reference source not found.(ungrounded samples). MilliQ water has been used as control in 
the same conditions. 
2.4. pH monitoring
2 mL of 2 % gelatin solution brought to 37 ⁰C were put in 24-well plates and treated with APPJ 
or kINPen at 10 mm nozzle distance and 1 L/min gas flow. Evolution of the pH as a function of 
plasma treatment time was measured by using a PC80 Multiparameter instrument 
(XS Instruments, Italy) with a Crison 50 14 electrode (Crison, Spain).
2.5. Infrared imaging of plasma-treated gelatin solution
Non-invasive temperature measurements were effectuated by means of an infrared camera 
(Fluke Ti480 by Fluke) with resolution of 640x640 pixels and an accuracy of ±2 °C. An initial 
calibration of the camera acquisition was effectuated using a standard thermocouple to 
measure the target temperature by contact. The emissivity was corrected with the calibration 
procedure. The camera was mounted 15 cm above the sample and focused on the sample 
surface. The acquisitions are reported on a scale from 10 to 40 °C so to accentuate the 
temperature gradients.
2.6. Detection of RONS
Quantification of plasma generated NO2- in 2% of gelatin solutions and in DI water was 
performed by Griess test1,4,40,41. Griess reagent (GR) was prepared by dissolution of 0.1 % wt/v of 
N-(1-naphthyl) ethylenediamine dihydrochloride, 1 % wt/v of sulphanilamide, and 5 % wt/v of 
phosphoric acid in DI water. 200 μL of GR were added on the 200 μL of plasma-treated sample 
in a 96-well plate (Figure 2a). Incubation of the plate protected from light was done for 10 min 
at room temperature before absorbance measurement at λ = 540 nm using a Synergy HTX Hybrid 
Multi Mode Microplate Reader (BioTek Instruments, Inc., USA). Calibration curves to correlate 
absorbance with concentration were made from NaNO2 standard solutions with proper 
dilutions.
Quantification of plasma generated H2O2 in 2% gelatin solution or in water was performed by 
fluorescence measurement from the conversion of H2O2 in resorufin (fluorescent product) using 
100 µM AmplexTMRed reagent with 0.25 U/mL HRP as catalyst. The plasma-treated 2% gelatin 
solution samples were diluted 1:200 to proceed to the detection of H2O2 within the linear 
concentration range. 50 µL of the reagent were added to 200 µL of the diluted samples in a 96-
well plate and that was incubated at 37 ⁰C for 30 min. Fluorescence measurements were 
performed using a Synergy™ HTX Multi-Mode Microplate Reader (Biotek, USA) using 560/20 nm 
and 590/20 nm as filters for excitation and emission wavelengths, respectively.  
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2.7. Stability of RONS
The time stability of H2O2 and NO2- after storage of the plasma-treated 2% gelatin solution was 
measured following the protocol previously described, for each of the species. Gelatin solutions 
was stored either at 4 ⁰C or 37 ⁰C. DI water was used as control.
2.8. Release of RONS from plasma-treated hydrogels
200 µL of 2% gelatin solution were treated by APPJ or kINPen in 96-well plate at 10 mm with gas 
flow rate of 1 L/min during 30, 90 and 180 s. Then, plasma-treated gelatin samples, together 
with untreated gelatin as control, were transferred into Corning® Transwell® cell culture inserts 
and placed in 1 mL of PBS used as release medium in 24-well plates. Release kinetics of RONS 
from the gelatin to the PBS were plotted from withdrawals of 100 µL of the release medium at 
determined time points. 50 µL were used for NO2- and 50 µL for H2O2 detection, following the 
same experimental protocol described for RONS detection in DI water. 100 µL of fresh PBS at 37 
˚C were replaced after each sample withdrawal. At the end of the release experiments, final 
volumes of the release media were measured to consider any water evaporation. Thus, two 
volume corrections were taken into account to determine precisely the concentration RONS in 
the release medium at each moment t: (i) a step to step correction due to sample withdrawal 
and (ii) a total volume correction due to evaporation. Gelatine solutions were treated by plasma 
immediately before starting the RONS release experiments (without any storage time). 
2.9. In vitro cell experiments 
Sarcoma osteogenic SaOS-2 cells were used to evaluate the cytotoxicity of the plasma-treated 
2% gelatin solutions on cancer cells. Cell culture medium of SaOS-2 consisted of Mc Coy´s 5A 
medium supplemented with 10% FBS and 1% P/S. Subconfluent SaOS-2 were detached from the 
flask using trypsin, centrifuged and seeded with a density of 10000 cells/well in 24-well plates 
with 1 mL volume of complete cell culture medium. After 6-hour adhesion, plasma-treated 2% 
gelatin solution samples were transferred to Transwell® inserts and placed in the wells. Gelatin 
solution used for cell experiments was previously heated at 37 ⁰C and filtered with 0.22 μm-
diameter pore Millex-GP filters (Millipore, Merck) before plasma treatment. Plasma treatments 
of the 2% gelatin solution used for in vitro cell experiments were performed with APPJ or kINPen 
for 30, 90 and 180 s using a 10 mm nozzle distance and 1 L/min gas flow rate. The same density 
of cells was seeded in the same conditions in empty well (cell only) and in presence of untreated 
gelatin, as controls. The cells were grown at 37 ⁰C for another 24 and 72 hours. 
Bone marrow-derived Mesenchymal Stem Cells (hMSC) were used to evaluate the selectivity of 
plasma-treated gelatin between cancer and healthy cell lines. Cell culture medium of hMSC 
consisted of AdvDMEM supplemented with 10% FBS and 1% P/S. Seeding, cell density and 
experimental design of hMSC were reproduced in the exact same conditions such as presented 
above with SaOS-2. hMSC cell viability was evaluated at 72 hours for cells in presence of 
untreated gelatin (control), APPJ- or kINPen-treated 2% gelatin solutions for the longest plasma 
treatment studied (180 s).
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Cell viability at 24 and 72 hours was evaluated with WST-1 reagent following supplier’s protocol. 
Absorbance was measured at λabs = 440 nm using a Synergy HTX Hybrid Multi Mode Microplate 
Reader (BioTek Instruments, Inc., USA). Normalization of the absorbance values was made with 
respect to cells only to determine the effects of untreated and plasma-treated 2% gelatin 
solution on SaOS-2 cell viability. Cell viability was also assessed by imaging the well plates by 
optical microscopy to check the coherence of the results.
2.10. Confocal Laser Scanning Microscopy 
SaOS-2 cells were seeded on round glass slides in the bottom of a 24-well plate with a density 
of 3.0x104 cells per well in 1 mL of McCoy´s 5A medium supplemented with 10% FBS and 1% P/S. 
After 6-hour adhesion, plasma-treated gelatin samples were transferred to Transwell® inserts 
and placed in the wells. The same density of cells was seeded in the same conditions without 
adding gelatin, as positive control. After 48 hours, SaOS-2 cells were fixed with 4% 
paraformaldehyde (PFA)/DPBS for 30 min at room temperature, 3x washed with PBS, and 
permeabilized with 0.1% Tween20/PBS during 30 min. They were washed three times with PBS 
and non-specifically points were blocked using SuperBlock™ (TBS) for 2 h. Then, cells were 3x 
washed and actin filaments were labelled using Alexa Fluor® 546 Phalloidin (AF546)/PBS in a 
dilution 1:300 to discern the cytoskeleton. After 1-hour incubation, samples were washed three 
times with PBS, and mounted using ProLong® Gold antifade with DAPI, allowing nuclei staining. 
SaOS-2 cells were imaged with a Zeiss LSM 800 Confocal Laser Scanning Microscope (CLSM) and 
processed with ZEN 2.3 software (Zeiss, Germany). Immunofluorescence images were taken 
using a 40x oil objective, using 557 nm and 353 nm as excitation wavelengths and 560-700 nm 
and 400-555 nm as detection wavelengths for AF546 and DAPI, respectively. 
2.11.  Data analysis
Statistical differences were determined using one-way ANOVA a 95% confidence with Tukey’s 
post-tests using Minitab 19 software (Minitab, Inc., State College, PA). Statistical significance 
was noted when p<0.05.
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3.1. Thermal effects of cold atmospheric plasma treatment 
Figure 1: Configuration of the plasma treatment of gelatin using an APPJ and kINPen (a) together with the physical 
aspect of gelatin as function of temperature (inset). Thermal effects after 180 s of plasma treatment of water or 2% 
gelatin solution using APPJ and kINPen (10 mm, 1 L/min) monitored by infrared camera. The temperature value is 
calculated as an average over the gelatine surface (b).
Plasma treatments of 200 µL gelatin solution and water have been performed using APPJ and 
kINPen. The temperature of the solution was measured by IR imaging before and after plasma 
treatment and comparative results are presented in Figure 1. While both water and gelatin 
remain around the initial temperature after 180 s plasma treatment for kINPen device, plasma 
treatment using APPJ induces cooling for both samples, with a decrease of 11 ˚C and 12 ˚C for 
gelatin and water, respectively. To study the contributions of the gas flow on the thermal effects 
caused on water and gelatin, controls with only gas flow were performed (Supplementary Figure 
1). Both devices are fed with high purity dry gas (Ar or He) which induces strong evaporation 
from the gelatin/water free surface. The thermal energy lost to evaporation induces a cooling 
of the sample as confirmed by only gas tests. Assuming the enthalpy of water vaporization in 
gelatin solution is the same as in pure water (2257 J/g), an evaporation of 100 µL over 180 s 
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results in a cooling power of approximately 1.25 W. On the other side, a portion of the total 
power consumed by the plasma sources (2.1 W for APPJ and 8.4 W for kINPen on the gelatin 
solution) is delivered to the target as heat through Joule effect or electromagnetic emission. 
While for APPJ the cooling effect is stronger than the heating one, for kINPen they are 
comparable. Both plasma devices warm the samples, but in the case of kINPen, the warming 
effect is sufficient to counterbalance the cooling effect of evaporation. This can be attributed to 
the different powers of the two sources. 
3.2. Influence of plasma treatment on the generation of RONS in gelatin
Figure 2b & c show the concentration of NO2- and H2O2 generated in 2% gelatin solution or 
distilled water as a function of the plasma treatment time, using APPJ or kINPen. Higher amount 
of NO2- and H2O2 was measured in 2% gelatin solution compared with water for any of the 
conditions studied. In both cases of hydrogel or water, production of RONS increases with the 
plasma treatment time. In DI water, NO2- concentration does not further increase after 2-min 
plasma treatment. Furthermore, production of RONS by kINPen is always higher than using APPJ 
in 2% gelatin solution and it is equal or higher for water, for similar plasma treatment times. 
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Figure 2. Plasma treatment of distilled water and 2% gelatin solution in presence of Griess reagent for NO2- detection 
(a). Influence of plasma treatment time on NO2- (b) and H2O2 (c) generation in APPJ- (i) and kINPen-treated (ii) 2% 
gelatin solution for 10 mm nozzle distance to the liquid surface and 1 L/min gas flow rate, together with the controls 
in DI water. Monitoring of the pH of 2% gelatin and DI water in the same conditions (d).  
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The pH of water decreases quickly at short plasma treatment times to below 3 after 900 s of 
treatment, while the pH of 2% gelatin solution remains between 5.5 and 6 up to 900 s (Figure 
2d), highlighting a pH buffering effect of the gelatin.
Figure 3. Influence of plasma gas flow rate distance on the concentration of NO2- (a) and H2O2 (b) from APPJ- and 
kINPen-treated 2% gelatin for 90 s. Different letters indicate statistically significant differences (mean sd, n=3; 
p<0.05).
Gas flow rate and distance from the nozzle to the surface of the liquid also play a significant role 
in the concentration of RONS generated in gelatin (Figure 3a) clearly indicates that higher 
concentrations of NO2- are generated in gelatin solution under low gas flow rate and short nozzle 
distance. [NO2-] is maximized for both plasma devices at 1 L/min of gas flow rate and 10 mm 
nozzle distance, with concentrations of 112 µM and 219 µM for APPJ and kINPen, respectively. 
Under the same working conditions, kINPen generates much more nitrites than APPJ for all 
conditions studied. In contrast, production of H2O2 in gelatin (Figure 3b) does not follow the 
same trend with APPJ with the variation of both nozzle distance and gas flow rates. kINPen 
displays an increase of H2O2 production with the decrease of the nozzle distance, as observed 
for NO2-. In parallel, variation of gas flow does not display variation in the generation of hydrogen 
peroxides in kINPen-treated gelatin at 15-20 mm but increases at short distance when increasing 
gas flow rate.   
3.3. Stability of RONS in gelatin-based hydrogel
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To study the stability of RONS generated in 2% gelatin solution NO2- and H2O2 were quantified 
at different times after plasma treatment, at two storage temperatures: 4 ⁰C and 37 ⁰C and 
compared to DI water as control (Figure 4).
Figure 4: Influence of the storage time and temperature on the ratio of RONS remaining with respect to the initial 
concentrations of NO2- (a) and H2O2 (b) in 2% gelatin and water generated by APPJ (left side) and kINPen (right side) 
plasma treatment (10 mm, 1 L/min, 90 s).
For both APPJ- and kINPen-treated water, a quick decrease of nitrites is observed as a function 
of the storage time, with a quicker disappearance of NO2- at 37 ⁰C than at 4 ⁰C. No nitrite ions 
were detected in water after 24h. This NO2- decreasing trend is slowed down in plasma-treated 
gelatin, wherein after 24 hours, around 90% and 55% of the initial concentration of NO2- remains 
in the biomaterial (for APPJ and kINPen, respectively). While almost all NO2- ions react within 
the first 24 hours in plasma-treated water, hydrogen peroxides are stable, even after hours. The 
same stability is observed in plasma-treated 2% gelatin solution, in which H2O2 concentration 
remains constant over 72-hour storage either at 4 ⁰C or 37 ⁰C.  To sum up, gelatin hydrogels 
improve the stability of plasma-generated RONS, as they allow maintaining constant 
concentration of NO2- and H2O2 over time.
3.4. Release studies of RONS from plasma-treated hydrogels
The release of NO2- and H2O2 from the plasma-treated 2% gelatin to PBS (Figure 5) shows a clear 
dependence of plasma treatment time. Higher release of NO2- and H2O2 was recorded for longer 
treatment times, according to the higher initial amount of RONS in the biopolymer. Similarly, 
the higher amount of RONS generated with kINPen (Figure 2 and Figure 3) result in higher 
concentrations of nitrites and peroxides released than from the APPJ-treated gelatin solution. 
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Figure 5. RONS released from APPJ- and kINPen-treated 2% gelatin solution for 30, 90 and 180 s plasma treatment 
(10 mm, 1 L/min) to PBS release medium: concentration of NO2- (a) and H2O2 (b). Untreated gelatin solution was 
employed as control. 
3.5. In vitro anticancer efficacy
Sarcoma osteogenic SaOS-2 cells were exposed to APPJ- and kINPen-treated 2% gelatin to 
evaluate the impact on cell viability (Figure 6a). As expected, untreated gelatin is completely 
biocompatible. The plasma-treated gelatin induced bone cancer cell death, with SaOS-2 cell 
viability decrease by increasing of treatment time, for both plasma devices tested, but being 
treatment with kINPen more effective on suppressing viability of osteosarcoma cells. Short 
plasma treatment times (30 s) already reveal important cytotoxic effects on SaOS-2 cells, with 
cell viability of 71% for APPJ and 57% for kINPen after 24 hours. Cell viability diminished to 46% 
and 27% after 24 hours for 180 s APPJ and kINPen treatment, respectively, and further 
decreased to 23% and 12% after 72 hours. Additionally, while SaOS-2 cells grow homogenously 
in the well plate when using untreated gelatin, SaOS-2 are killed preferentially just below the 
insert with the treated gelatin (lack of cells in this area). The diameter of this area of arrested 
proliferation increases with plasma treatment time, with absence of living cells for longer plasma 
treatment times in this area (Supplementary Figure 2). It can be assumed that this corresponds 
to the area of diffusion of RONS nearer the plasma-treated gelatin solution, confirming that the 
release of RONS is closely linked with the biological effects observed.
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Figure 6.  SaOS-2 cell viability after 24 h and 72 h exposition to APPJ) and kINPen (K)-treated 2% gelatin for 30, 90 
and 180 s (a). Selectivity of plasma-treated gelatin for 180 s using APPJ and kINPen (10 mm, 1 L/min) (b). Different 
letters indicate statistically significant differences (mean sd, n=3; p<0.05).  Confocal microscopy images of SaOS-2 
cells placed for 48 hours in presence of untreated gelatin (control) and APPJ-treated gelatin for 90 s at 1 L/min and 
10 mm (c).
Confocal microscopy images (Figure 6b) confirm the previous results; SaOS-2 cells in presence 
of untreated gelatin display the same morphology than control with cells only. APPJ-treated 
gelatin induces morphological modifications reflected by a reduction of the expansion or an 
absence of actin filaments and a reduction of the nuclei size. 
Finally, the selectivity of the plasma-treated biomaterial was also tested with hMSC in presence 
of APPJ and kINPen-treated 2% gelatin solution for 180 seconds as presented in Figure 6c. While 
Page 13 of 25
ACS Paragon Plus Environment






























































presence of untreated gelatin solution with hMSC confirms the biocompatible behavior of the 
material with 72-hour cell viability around 91%, the results revealed that plasma treatments of 
gelatin in the studied conditions have selective effects on cancer cells, maintaining cell viability 
of healthy cells of 91.9 ± 3.4% and 86.8 ± 4.5% for 180 s APPJ and kINPen treatment, respectively.
4. DISCUSSION
Many studies have shown proof of the anticancer efficacy of plasma-conditioned liquids (PCL) 
such as physiological saline solutions or culture media9,10,12,14,42–45. As alternative to direct 
treatment of cancer cells by CAP46,47, that could results more aggressive for healthy cells, the use 
of PCL presents the advantage of being a minimally-invasive approach with similar in vitro 
results, including better outcomes especially regarding selectivity. However, one of their 
limitations is that while they can be delivered locally, the liquids can be quickly washed away by 
body fluids. Here, the production of RONS by plasma jets was enhanced by using a polymer 
solution of gelatin (Figure 2) with respect to other saline solutions45 or to the first work 
evaluating a biopolymer solution of alginate16. This opens the door to entrapping these RONS in 
a biopolymer formulation able to act as vehicle for local delivery of RONS for cancer therapy, 
potentially allowing extended local therapy with the RONS in the tumor site (Figure 4) rather 
than the conventional plasma-conditioned saline solutions. 
Gelatin has been widely used as carrier material for therapeutic cells and drugs due to their 
excellent biocompatibility and similarities to the extracellular matrix48. To meet the stringent 
requirements of clinical translation of the hydrogels such preparation, application, mechanical 
properties, etc. a number of modifications of gelatin have also been investigated49. 
Until now, some works have investigated the diffusion of RONS from plasma jets through gelled 
(solid) gelatin34,35,50 and agarose36,51–54, used as tissue models in plasma medicine. These studies 
showed that plasma treatment of mm thick gelled gelatin or agarose allow the diffusion of 
reactive species to a liquid below, as it is thought to happen in vivo, with RONS going through 
the skin. 
Our approach here is novel, as we treat liquid gelatin solutions with cold atmospheric plasma 
jets to generate RONS within it with the aim to include afterward the plasma-treated biopolymer 
in the design/formulation of a biomaterial able to act as a delivery system. 
Different works55 have investigated the production of RONS in water or saline solutions under a 
broad range of conditions such as volume, treatment time, gas flow and electrode 
distance2,45,51,56–58. To allow easier extrapolation of results, two plasma jets were employed here. 
Despite that the great variety of configurations in the plasma literature hamper comparative 
analysis, it is clear that employing a gelatin solution here leads to much higher generation of 
RONS. Plasma treatment of the 2% gelatin solution allowed obtaining high concentrations of 
nitrites and peroxides (Figure 2 & 3). In water (used as control), the concentrations of NO2- and 
H2O2 generated agree with those observed in plasma-conditioned water in previous works55,56 
using an APPJ in very similar conditions (20 mm, 100 µL) to those employed here. As in our work, 
the amount of RONS generated increases with plasma treatment time.  
Nevertheless, compared to DI water, the amount of RONS generated in 2% gelatin solution is 
much higher with any of the two plasma jets investigated here (APPJ or kINPen) (Figure 2). After 
3 min of plasma treatment, the amounts of NO2- and H2O2 generated in gelatin are at least 2 
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times higher than in water and can reach up to 4.1 and 7.4 fold for NO2- with APPJ and kINPen, 
respectively. This enhanced production of RONS in a biopolymer solution than in water or 
Ringer’s saline was also observed in our previous work with alginate solutions59. This difference 
can be explained by the pH buffering effect of the gelatin solution; while pH decreased with 
plasma treatment time in Ringer’s saline59 or water (Figure 2d), as also reported in other works60–
62, the pH remained unaltered in buffered saline such as PBS, in alginate59 or here in gelatin 
solution. In general, different reactions are fostered in acidic media: NO2- reacts with H2O2 to 
form peroxynitrites; nitrous acid – one of the major sources of nitrites - decomposes in acidic 
media)4,55,63,64, among other reactions. Since plasma treatment leads to water acidification, 
these reactions are promoted in water. However, as gelatin solutions are not displaying 
acidification (Figure 2d) the reactions consuming peroxides and nitrites are slowed down, 
leading to higher stability of these RONS. While this hypothesis is clearly a common trend 
between plasma-treated gelatin solution and plasma-treated alginate solution59, the present 
work demonstrates that the specific polymer employed to produce the solution is also a 
keypoint regarding the chemical reactivity of the solution with the plasma gas phase. Gelatin 
solutions are able to generate several-fold higher concentrations of RONS than alginate 
solutions (i.e. 226.4 μM of NO2- and 740 μM of H2O2 were generated in gelatin solution vs. 97.2 
μM of NO2- and 111.9 μM of H2O2, in alginate solution under same conditions - 90 s of kINPen 
treatment in  200 μL of solution at 10 mm distance and 1 L/min Ar flow rate).
Parameters such as plasma gas flow rate or nozzle distance to the liquid surface can be modified 
to obtain maximum NO2- and H2O2 concentrations in the liquids treated. Here we observed that 
NO2- are maximized at short nozzle distance and low gas flow rate, while short distances and 
high gas flow rates promote higher concentrations of H2O2 (Figure 3). As recorded in a previous 
work, production of RONS is more efficient under same treatment conditions using kINPen than 
APPJ59 (Figure 2 and Figure 3). One of the reasons supporting this difference between both 
devices could lie with the thermal effects observed in Figure 1b that can affect fluid dynamics 
and thus generation of RONS. While plasma treatment using kINPen is maintaining the 
temperature of the polymer solution or the water during plasma-treatment for a same gas flow 
rate and nozzle distance, the cooling down observed with the samples treated with APPJ may 
affect the diffusion of the reactive species inside the plasma-treated polymer solution due to its 
higher viscosity, as gelatin starts jellying at temperatures from 25-28 ˚C depending on the 
concentration and the length of the chain, among others65. Lower temperatures revert in a 
material tending to get a more solid-like behavior, limiting thus the diffusion and generation of 
RONS inside the polymer network. The difference of behavior in the thermal effects of the 
samples between APPJ and kINPen most likely arise from the difference of power delivered by 
both plasma sources. Since the water content in the gas flow is zero in both cases, and thus the 
contribution of the cooling effect due to evaporation is the same, it can be assumed that the 
higher power delivered to the plasma discharge by the kINPen (between 0.3 and 3.5 W66) with 
respect to the power delivered by the APPJ (0.3 W measured) is the main reason of the higher 
counterbalancing in the warming effect presented by the kINPen.
Another important difference between the two sources comes from the type of gas used (He for 
the APPJ and Ar for the kINPen). Assuming a kinematic viscosity of 1.11x10-4 m2/s for He and of 
1.27x10-5 m2/s for Ar, for the gas flow rates (1-5 L/min) and the nozzle diameters (APPJ Ø 1.2 
mm, kINPen Ø1.6 mm) adopted in this work the Reynolds number (Re) ranges between 158 and 
792 for the APPJ in He and between 1042 and 5200 for the kINPen in Ar. As reported in the 
literature for a similar jet configuration, a transition from laminar to turbulent flow is expected 
to occur for Re between 500 and 1000. Thus, it can be assumed that the APPJ operates mostly 
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in a laminar flow regime while the kINPen in a turbulent one. The turbulent vortexes in the 
kINPen effluent, while limiting the length of the plasma plume (see in Figure 3 the rapid decrease 
of RONS with increase of the gap distance), can certainly favor the mixing with surrounding air 
and therefore allow higher production of RONS with respect to the APPJ67,68.
Furthermore, the buffering effect observed here in gelatin solution (Figure 2b (i and ii)) may also 
have two important implications: 1. Cancer cells are known to acidify their environment and, 
consequently, the interior of the cells themselves is alkalinized. This reverse pH gradient is 
associated with tumor proliferation, invasion, metastasis, aggressiveness, and treatment 
resistance69–75, so the fact of having a buffered delivery vehicle for the plasma-generated RONS 
(instead of the acidic plasma-treated liquids proposed earlier) might be an advantage which 
should deserve investigation in future works. 2. A more practical advantage of this pH buffering 
of gelatin is that it allows the use of the Amplex Red method for detection of H2O2, since the 
HRP enzyme employed in this method remains stable in a pH range between 5.0 and 9.0. 
In designing biomaterials, the ability to store them is a practical and important asset in views of 
future commercialization. Interestingly, storage of plasma-treated DI water and gelatin at 4 ⁰C 
or physiological conditions (37 ⁰C) revealed that NO2- is more stable in the gelatin solution with 
respect to water (Figure 4). Whereas almost all the nitrites generated in water disappeared after 
24 hours, at least 60% of the initial concentration of nitrites generated in 2% gelatin remained 
in the material after 72 hours. Meanwhile, H2O2 presents a good stability over time up to 72 
hours, either for water or gelatin solution, with at least 84.9% of the initial concentration of 
hydrogen peroxides remaining in gelatin solution after 3-day storage. This trend is not only in 
accordance with a previous work monitoring storage of H2O2 in water over 21 days60, but above 
all it highlights a better conservation of H2O2 in water or gelatin than observed in cell culture 
media, such as DMEM76, where H2O2 concentrations reported were 10 times lower after 24 
hours.  
Release kinetics of NO2- and H2O2 from APPJ- and kINPen-treated gelatin solution to PBS, clearly 
show that higher amounts of RONS were released from treated gelatin solution for longer 
treatment times (Figure 5). A sustained release of NO2- can be observed up to 48 hours, whereas 
H2O2 shows burst release, with maximum released after 4-6 hours. While 180 s plasma-treated 
gelatin solution releases 75% of NO2- generated with APPJ and 67% with kINPen after 72 hours, 
the release percentage of H2O2 to PBS is much lower, with values of 7% and 15%, respectively 
(Supplementary Table 1). However, despite the low release percentage of hydrogen peroxides, 
the concentrations released allow to observe significant biological effects of SaOS-2 cells (Figure 
5). 
Osteosarcoma (SaOS-2) cell death was enhanced progressively with plasma-treated gelatin at 
increasing treatment times (Figure 6a). This can be related to the increasingly higher 
concentration of RONS produced by plasma jet (Figure 7). This death of cancer cells in a dose-
dependent manner has been previously associated with biological and molecular mechanisms 
of necrosis, apoptosis, senescence, and autophagy triggered by CAP treatment77. With [H2O2] 
around 200 μM after 30 s of plasma treatment, cytotoxic effects are already observed with the 
shortest plasma treatment time. Slightly higher cell cytotoxicity with kINPen than with APPJ can 
be directly related with the higher amount of RONS generated in the gelatin solution with this 
plasma jet (Figure 2 and Figure 3). By producing higher amounts of RONS in gelatin than in 
alginate solutions under the same plasma treatment conditions16, an important enhancement 
of cancer cell cytotoxicity is reached by using gelatin solutions, with 72-hour cell viability 
decreasing down to 12% by using kINPen for 180 s when alginate solutions presented a SaOS-2 
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cell viability of 62% for the same CAP treatment conditions. This supports to employ 
preferentially gelatin as biopolymer solution in a further design of CAP-treated biopolymer-
based biomaterial to obtained higher loading of RONS and thus, an improve effectiveness in 
killing cancer cells.   
Figure 7: Relationship between NO2- (a) and H2O2 (b) generated in 2% gelatin solutions and the cytotoxicity observed 
in SaOS-2 cell viability after 24 hours for APPJ and kINPen treatments (10 mm, 1 L/min).
Morphology and cell density imaged by confocal microscopy (Figure 6b) backup the discussed 
cellular results for gelatin solution. SaOS-2 osteosarcoma cells in presence of either untreated 
hydrogels present extended actin filaments and high cell density, accordingly to their suitable 
biocompatibility (Figure 5a). On the contrary, osteosarcoma cells cultured with plasma-treated 
gelatin show isolated cells, with fewer adhesion points, smaller nuclei size and more rounded 
shape, all indicative of the dying fate induced by the plasma-treated biopolymer solutions 
developed here. Finally, and most importantly, plasma-treated gelatin revealed a selective 
killing effect on osteosarcoma cells since cell viability of healthy cells (hMSC) is maintained above 
90% after 72 hours (Figure 6c). This selective behavior observed with plasma-treated biopolymer 
solution is in accordance with results obtained in previous works using plasma-conditioned 
liquids 15,78,79. As hypothesized for PCL, the mechanism behind this selectivity mainly takes its 
origin in the difference in basal levels of oxidative stress between healthy and cancer cells 
lines 8,12. So, plasma treatment of biopolymer solutions discussed here has several advantages 
regarding generation and stability of RONS, and above all preserve the biological effects 
observed with PCL. 
5. CONCLUSIONS
Herein we designed and characterized a novel vehicle for atmospheric pressure plasma-
generated RONS by comparing two different atmospheric pressure plasma jets. Gelatin solution 
greatly increases (between 2 and 12-fold) the concentration of RONS produced by cold 
atmospheric plasma with respect to water. The stability of NO2- generated in gelatin was 
enhanced and that of H2O2 was maintained with respect to DI water at least for 72 h. Plasma-
treated gelatin solution buffered the pH decrease observed in water which can be an advantage 
and partially explains the higher RONS measured. Anticancer effects of plasma-treated gelatin 
solution are time-dependent in SaOS-2 osteosarcoma cells, being closely related with the 
increase of RONS generated by plasma at longer treatment times that reverts in a higher release 
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of RONS. Plasma-treated gelatin solution revealed a selective lethality on osteosarcoma cells 
since cell viability of healthy hMSC cells is maintained above 86% after 72 hours for the longest 
plasma treatment studied (3 min), while viability of SaOS-2 decreased to 23% and 12% for APPJ 
and kINPen, respectively. The set of unique features previously described make of gelatin a great 
candidate for the generation and storage of RONS generated by cold atmospheric plasmas and 
a relevant material to be used in the design of implantable delivery system, with promising 
applicability in cancer therapy. 
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